Business
IFRS 9 Transition Report
IFRS 9 Transition Report.
About this update from Close Brothers Group Plc
[{"type":"text","content":"\n \nRNS Number : 5458G Close Brothers Group PLC 07 November 2018 \n\n\n\n\n\n \n \n \nIFRS 9 Transition Report\n\n\n \n\n\n\n\n \nClose Brothers Group plc (\"Close Brothers\" or \"the group\") has today published an IFRS 9 transition report, now available to view on our website:\n \nhttps://www.closebrothers.com/investor-relations/investor-information/results-reports-and-presentations\n \nThe report is designed to assist the reader in understanding the impact on Close Brothers of the adoption of IFRS 9 Financial Instruments, which replaces IAS 39 Financial Instruments: Recognition and Measurement. \n \nThe report provides further details on the implementation of IFRS 9 Financial Instruments and on the movement from IAS 39 reported numbers, as included in the Close Brothers Annual Report 2018. IFRS 9 is effective for the group from 1 August 2018. \n \nThere has been no change to the previously reported impact of IFRS 9 on the group's balance sheet and capital position at 1 August 2018, which remain as stated in the group's preliminary results announcement on 25 September 2018. \n \n \n \nEnquiries\n \n\n\n\n\nSophie Gillingham\n\n\nClose Brothers Group plc\n\n\n020 7655 3844\n\n\n\n\nMatt Bullivant\nAndy Donald\n \n\n\nClose Brothers Group plc\nMaitland\n\n\n020 7655 3698\n020 7379 5151\n\n\n\n\n \nAbout Close Brothers\n \nClose Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.\n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END MSCFKADBOBDDDDK\n ","length":4610,"tagName":"div"}]